Gudeta Adugna Negussie, Lind Alexander, Girma Alemayehu, Lempainen Johanna, Ilonen Jorma, Agardh Daniel
Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Department of Microbiology, Arsi University, Asella, Ethiopia.
Pediatr Diabetes. 2025 Aug 17;2025:8258430. doi: 10.1155/pedi/8258430. eCollection 2025.
Autoantibodies against β-cell components in the pancreatic islets of Langerhans are characteristic of type 1 diabetes (T1D). The genetic and autoimmune determinants of type 1 diabetes (T1D) in Ethiopians are not yet thoroughly characterized, with studies indicating a lower occurrence of autoantibodies related to T1D compared to Caucasians. The study aimed to determine the occurrence of autoantibodies related to type 1 diabetes (T1D), celiac disease (CD), and autoimmune thyroid disease (AITD) in conjunction with Human Leukocyte Antigen (HLA) genotype in Ethiopian children and adolescents with T1D. This cross-sectional study included 206 children and adolescents with T1D (ranging from 1 to 18 years old) with a median disease duration of 6 years, alongside 200 age-matched control children (ranging from 1 to 6 years old). Participants were recruited from Adama, Asella, and Bishoftu Hospitals in Ethiopia. The study involved genotyping of HLA alleles, specifically HLA-DQA1, DQB1, and DRB1 04 (including DR4 subtypes). Additionally, autoantibodies targeting glutamic acid decarboxylase (GADA), insulinoma-associated protein (IA-2A), zinc transporter 8 (ZnT8A), tissue transglutaminase (tTGA), and thyroid peroxidase (TPOA) were analyzed using antibody detection by agglutination PCR (ADAP) assays. The most common haplotype found in participants with T1D was HLA-(DR3)-DQA1 05-DQB1 02 haplotype (36.4%) (OR = 5.0; < 0.000001). In addition, HLA-DRB1 0405-DQA1 03-DQB1 02 (19.3%, OR = 10.8; < 0.000001), HLA-DRB1 0405-DQA1 03-DQB1 0302 (9.2%, OR = 3.1; =0.001), and HLA-DRB1 0401-DQA1 03-DQB1 0302 (3.2%, OR = 20.0; =0.002) were significantly increased among T1D patients. Conversely, HLA-(DR15)-DQB1 0602, HLA-(DR13)-DQB1 0603, HLA-(DR1/10)-DQB1 0501, HLA-(DR13)-DQB1 0604, HLA-DRB1 0404-DQA1 03-DQB1 04, HLA-(DR7)-DQA1 0201-DQB1 02, HLA-(DR11/12/13)-DQA1 05-DQB1 0301, and HLA-DRB1 0403-DQA1 03-DQB1 0302 were noted as the most protective haplotypes with a significant value and, with ORs ranging from 0.05 to 0.5. The overall frequency of any islet autoantibodies in children and adolescents with T1D was 81.1% compared to 5.5% in the control group ( < 0.0001). While comparing antibody positivity between individuals with T1D and controls, GADA was found in 69% versus 2%, IA-2A in 24% versus 1.5%, ZnT8A in 32% versus 2%, tTGA in 14% versus 2%, and TPOA in 17% versus 5%, respectively ( < 0.0001). Individuals carrying DR4-DQ8 or DR3-DQ2 haplotypes exhibited a higher prevalence of IA-2A and tTGA ( ≤ 0.05). The HLA risk profile typical of sub-Saharan African population was observed in Ethiopians with T1D. Furthermore, they have a notably high prevalence of autoantibodies associated with T1D, CD, and AITD, which differs from earlier reports from the region but aligns with patterns observed in Caucasians.
针对胰岛β细胞成分的自身抗体是1型糖尿病(T1D)的特征。埃塞俄比亚人1型糖尿病(T1D)的遗传和自身免疫决定因素尚未得到充分表征,研究表明,与高加索人相比,与T1D相关的自身抗体发生率较低。该研究旨在确定埃塞俄比亚T1D儿童和青少年中与1型糖尿病(T1D)、乳糜泻(CD)和自身免疫性甲状腺疾病(AITD)相关的自身抗体的发生率,并结合人类白细胞抗原(HLA)基因型进行研究。这项横断面研究纳入了206名T1D儿童和青少年(年龄在1至18岁之间),疾病中位持续时间为6年,同时纳入了200名年龄匹配的对照儿童(年龄在1至6岁之间)。参与者来自埃塞俄比亚的阿达马、阿塞拉和比绍夫图医院。该研究涉及HLA等位基因的基因分型,特别是HLA-DQA1、DQB1和DRB1 04(包括DR4亚型)。此外,使用凝集PCR抗体检测(ADAP)分析法分析了针对谷氨酸脱羧酶(GADA)、胰岛素瘤相关蛋白(IA-2A)、锌转运体8(ZnT8A)、组织转谷氨酰胺酶(tTGA)和甲状腺过氧化物酶(TPOA)的自身抗体。在T1D参与者中发现的最常见单倍型是HLA-(DR3)-DQA1 05-DQB1 02单倍型(36.4%)(OR = 5.0;< 0.000001)。此外,HLA-DRB1 0405-DQA1 03-DQB1 02(19.3%,OR = 10.8;< 0.000001)、HLA-DRB1 0405-DQA1 03-DQB1 0302(9.2%,OR = 3.1;= 0.001)和HLA-DRB1 0401-DQA1 03-DQB1 0302(3.2%,OR = 20.0;= 0.002)在T1D患者中显著增加。相反,HLA-(DR15)-DQB1 0602、HLA-(DR13)-DQB1 0603、HLA-(DR1/10)-DQB1 0501、HLA-(DR13)-DQB1 0604、HLA-DRB1 0404-DQA1 03-DQB1 04、HLA-(DR7)-DQA1 0201-DQB1 02、HLA-(DR11/12/13)-DQA1 05-DQB1 0301和HLA-DRB1 0403-DQA1 03-DQB1 0302被认为是最具保护作用的单倍型,具有显著的 值,OR值范围为0.05至0.5。T1D儿童和青少年中任何胰岛自身抗体的总体频率为81.1%,而对照组为5.5%(< 0.0001)。在比较T1D个体和对照组的抗体阳性率时,发现GADA的阳性率分别为69%和2%,IA-2A为24%和1.5%,ZnT8A为32%和2%,tTGA为14%和2%,TPOA为17%和5%(< 0.0001)。携带DR4-DQ8或DR3-DQ2单倍型的个体IA-2A和tTGA的患病率较高(≤ 0.05)。在患有T1D的埃塞俄比亚人中观察到了撒哈拉以南非洲人群典型的HLA风险特征。此外,他们中与T1D、CD和AITD相关的自身抗体患病率显著较高,这与该地区早期报告不同,但与在高加索人中观察到的模式一致。